Fibroblast growth factor 10 ameliorates renal ischaemia–reperfusion injury by attenuating mitochondrial damage
Abstract Ischaemia–reperfusion (I/R) injury is one of the leading causes of acute kidney injury (AKI). Its pathologic mechanism is quite complex, involving oxidative stress, inflammatory response, autophagy, and apoptosis. Fibroblast growth factor 10 (FGF10) and 5‐hydroxydecanoate (5‐HD) play essential roles in kidney injury. Rats were divided into four groups: (i) sham group, sham‐operated animals with an unconstructed renal artery; (ii) I/R group, kidneys were subjected to 50 min of ischaemia followed by reperfusion for 2 days; (iii) I/R + FGF10 group, animals treated with 0.5 mg/kg FGF10 (i.p.) 1 h before ischaemia; and (iv) 5‐HD group, animals treated with 5 mg/kg 5‐HD (i.m.) 30 min before FGF10 treatment. Renal injury, apoptosis damage, mitochondrial oxidative damage, mitochondrial membrane potential (MMP), and expression of the ATP‐sensitive K+ (KATP) channel subunit Kir6.2 were evaluated. FGF10 treatment significantly alleviated I/R‐induced elevation in the serum creatinine level and the number of terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end labelling–positive tubular cells in the kidney. In addition, FGF10 dramatically ameliorated renal mitochondrial‐related damage, including reducing mitochondrial‐dependent apoptosis, alleviating oxidative stress, maintaining the mitochondrial membrane potential, and opening the mitochondrial KATP channels. The protective effect of FGF10 was significantly compromised by the ATP‐dependent potassium channel blocker 5‐HD. Our data suggest that FGF10 offers effective protection against I/R and improves animal survival by attenuating mitochondrial damage..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Clinical and Experimental Pharmacology and Physiology - 50(2023), 1, Seite 59-67 |
| Beteiligte Personen: |
Yu, Lixia [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2023 John Wiley & Sons Australia, Ltd. |
|---|
| Umfang: |
9 |
|---|
| doi: |
10.1111/1440-1681.13724 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY003390675 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY003390675 | ||
| 003 | DE-627 | ||
| 005 | 20230307125413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230213s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/1440-1681.13724 |2 doi | |
| 028 | 5 | 2 | |a CEP_CEP13724.xml |
| 035 | |a (DE-627)WLY003390675 | ||
| 035 | |a (WILEY)CEP13724 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.38 |2 bkl | ||
| 100 | 1 | |a Yu, Lixia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Fibroblast growth factor 10 ameliorates renal ischaemia–reperfusion injury by attenuating mitochondrial damage |
| 264 | 1 | |c 2023 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 John Wiley & Sons Australia, Ltd. | ||
| 520 | |a Abstract Ischaemia–reperfusion (I/R) injury is one of the leading causes of acute kidney injury (AKI). Its pathologic mechanism is quite complex, involving oxidative stress, inflammatory response, autophagy, and apoptosis. Fibroblast growth factor 10 (FGF10) and 5‐hydroxydecanoate (5‐HD) play essential roles in kidney injury. Rats were divided into four groups: (i) sham group, sham‐operated animals with an unconstructed renal artery; (ii) I/R group, kidneys were subjected to 50 min of ischaemia followed by reperfusion for 2 days; (iii) I/R + FGF10 group, animals treated with 0.5 mg/kg FGF10 (i.p.) 1 h before ischaemia; and (iv) 5‐HD group, animals treated with 5 mg/kg 5‐HD (i.m.) 30 min before FGF10 treatment. Renal injury, apoptosis damage, mitochondrial oxidative damage, mitochondrial membrane potential (MMP), and expression of the ATP‐sensitive K+ (KATP) channel subunit Kir6.2 were evaluated. FGF10 treatment significantly alleviated I/R‐induced elevation in the serum creatinine level and the number of terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end labelling–positive tubular cells in the kidney. In addition, FGF10 dramatically ameliorated renal mitochondrial‐related damage, including reducing mitochondrial‐dependent apoptosis, alleviating oxidative stress, maintaining the mitochondrial membrane potential, and opening the mitochondrial KATP channels. The protective effect of FGF10 was significantly compromised by the ATP‐dependent potassium channel blocker 5‐HD. Our data suggest that FGF10 offers effective protection against I/R and improves animal survival by attenuating mitochondrial damage. | ||
| 700 | 1 | |a Yi, Xiaojiao |4 aut | |
| 700 | 1 | |a Yu, Cailong |4 aut | |
| 700 | 1 | |a Wang, Fugen |4 aut | |
| 700 | 1 | |a Tan, Xiaohua |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and Experimental Pharmacology and Physiology |g 50(2023), 1, Seite 59-67 |w (DE-627)WLY003385043 |x 14401681 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2023 |g number:1 |g pages:59-67 |g extent:9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.38 |q ASE |
| 951 | |a AR | ||
| 952 | |d 50 |j 2023 |e 1 |h 59-67 |g 9 | ||